Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 2,645,852 $ 279,772
Accounts receivable, net 750 8,000
Grant receivable 186,668
Prepaid expenses 213,283 31,458
Total current assets 3,046,553 319,230
Property and equipment, net 148,300 44,369
Right to use assets 458,707
Other assets:    
Patents,net 13,736 15,200
Intellectual property, net 224,010 236,000
Deposits, long term 41,936 13,422
Total other assets 279,682 264,622
Total assets 3,933,242 628,221
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $391,209 and $32,318, respectively 2,027,380 1,554,652
Deferred revenue, short term 134,924 209,474
Lease liability, short term 76,977
Convertible notes payable, net of debt discount of $0 and $656,231 3,503,769
Notes payable, net of debt discounts of $0 and $127,419 21,480 569,061
Notes payable, related party 290,110 290,110
Total current liabilities 2,550,871 6,127,066
Long term liabilities:    
Royalty obligation - net of discount of $6,812,318 and $0, related parties 1,909,782
Deferred revenue, long term 103,313 207,523
Lease liabilities, Long term 428,162
Total liabilities 4,992,128 6,334,589
Commitments and contingencies  
Deficit:    
Preferred stock, no par value, 600,000 authorized  
Common stock, $0.001 par value; 750,000,000 shares authorized, 5,326,852 and 2,597,347 shares issued and outstanding as of December 31, 2019 and 2018, respectively 5,327 2,597
Common stock subscribed 100,000 100,000
Additional paid in capital 60,111,429 49,418,356
Accumulated deficit (61,216,080) (55,176,450)
Total deficit attributable to BioCorRx, Inc. (977,708) (5,633,881)
Non-controlling interest (81,178) (72,487)
Total deficit (1,058,886) (5,706,368)
Total liabilities and deficit 3,933,242 628,221
Series A Preferred Stock [Member]    
Deficit:    
Preferred stock, no par value, 600,000 authorized 16,000 16,000
Series B Preferred Stock [Member]    
Deficit:    
Preferred stock, no par value, 600,000 authorized $ 5,616 $ 5,616